Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Trials Monitoring Service
Royds, Robert
Search 20 grants from Robert Royds
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Accord
Understanding CLIM2 functions in vivo using transgenic RNAi
Prevention of Urinary Tract Infection in Pts W/ Sci
Core - Research Pharmacy
Core - Protein and Peptide
Recently added grants:
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
Control of B cell differentiation by IFNg induced transcription factors
Effect of Microbial Metabolites on Growth of Cryptosporidium
Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE)
Evaluation of a High-Affinity and BTLA-specific HVEM Protein Agonist in vivo
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N02CM37106-8-0-0
Application #
7542218
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$2,212,786
Indirect Cost
Related projects
NIH 2008
N02 CA
Clinical Trials Monitoring Service
/ Theradex Systems, Inc.
NIH 2007
N01 CA
Clinical Trials Monitoring Service
Royds, Robert /
$2,212,786
NIH 2007
N01 CA
Clinical Trials Monitoring Service
/
$2,212,786
Comments
Be the first to comment on Robert Royds's grant